Moderna (MRNA)

CapEx to Revenue

25.52%

Quarterly · Period ending:

MRNA logo

MRNA CapEx to Revenue

Latest reported25.52%
MRNA Quarterly CapEx/Revenue (24.27% → 25.52%)
High-resolution chart · PNG

MRNA capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
25.5172%
15.9383%
5.7522%
3.248%
2.1127%
118.6916%
54.6025%
8.1402%
82.3529%
117.3653%
7.8208%
7.6461%
68.0233%
6.148%
1.7868%
2.764%
1.9054%
2.2222%
1.7269%
2.0501%
0.7117%
2.008%
4.0826%
12.2171%
28.081%
74.1805%
47.3995%
39.3699%
80.9142%
47.3947%
38.4998%
62.6003%
118.1242%
109.8833%
13.0136%
68.5094%
24.2736%
24.2736%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.